Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Pfizer Inc (PFE)

Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 157,475,296
  • Shares Outstanding, K 5,662,542
  • Annual Sales, $ 58,496 M
  • Annual Income, $ 2,119 M
  • 60-Month Beta 0.63
  • Price/Sales 2.68
  • Price/Cash Flow 9.31
  • Price/Book 1.75
Trade PFE with:

Options Overview Details

View History
  • Implied Volatility 23.18% ( -0.85%)
  • Historical Volatility 25.81%
  • IV Percentile 31%
  • IV Rank 30.99%
  • IV High 33.73% on 10/27/23
  • IV Low 18.44% on 06/09/23
  • Put/Call Vol Ratio 0.74
  • Today's Volume 175,286
  • Volume Avg (30-Day) 184,728
  • Put/Call OI Ratio 0.97
  • Today's Open Interest 3,312,783
  • Open Int (30-Day) 3,146,673

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 21 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate 0.45
  • Number of Estimates 7
  • High Estimate 0.54
  • Low Estimate 0.32
  • Prior Year 0.67
  • Growth Rate Est. (year over year) -32.84%

Price Performance

See More
Period Period Low Period High Performance
1-Month
25.20 +10.36%
on 04/26/24
27.94 -0.47%
on 05/02/24
+0.59 (+2.17%)
since 04/03/24
3-Month
25.20 +10.36%
on 04/26/24
28.69 -3.07%
on 03/13/24
+0.88 (+3.27%)
since 02/02/24
52-Week
25.20 +10.36%
on 04/26/24
40.37 -31.10%
on 06/13/23
-10.64 (-27.67%)
since 05/03/23

Most Recent Stories

More News
3 No-Brainer Stocks to Buy in May

These great stocks are great picks for investors as spring winds down.

LLY : 734.97 (-2.77%)
PFE : 27.81 (+0.40%)
VRTX : 401.08 (+0.23%)
Can Pfizer Challenge Lilly and Novo Nordisk in the Obesity Market?

Where there's a will, there's a way. And Pfizer appears to have the will to stake a claim in the massive obesity drug market.

LLY : 734.97 (-2.77%)
PFE : 27.81 (+0.40%)
3 High-Yield Dividend Stocks to Buy Now and Hold at Least a Decade

These highly advantaged businesses have what they need to keep raising their dividend payouts.

AET.LN : 50.200 (+3.51%)
CVS : 55.90 (+1.36%)
ARCC : 20.61 (+0.34%)
PFE : 27.81 (+0.40%)
My Top 5 Favorite High-Yield Dividend Stocks to Buy in May

Income investors can buy in May and go away with these stocks.

ARCC : 20.61 (+0.34%)
CVX : 160.25 (-0.30%)
EPD : 28.10 (+0.18%)
PFE : 27.81 (+0.40%)
VZ : 38.89 (-0.10%)
Pfizer's Stock Is a Buy. Here Are Six Reasons Why.

The pharma-giant's shares could be poised for a trend reversal.

PFE : 27.81 (+0.40%)
Pfizer (PFE) Q1 2024 Earnings Call Transcript

PFE earnings call for the period ending March 31, 2024.

PFE : 27.81 (+0.40%)
Why Pfizer Stock Blasted More Than 6% Higher Today

A double beat on earnings, plus raised bottom-line guidance, made the company a hot item on Hump Day.

PFE : 27.81 (+0.40%)
Pfizer: Q1 Earnings Snapshot

Pfizer: Q1 Earnings Snapshot

PFE : 27.81 (+0.40%)
Stock Index Futures Slip as Investors Await Fed Rate Decision, U.S. PMI and Jobs Data on Tap

June S&P 500 E-Mini futures (ESM24) are down -0.42%, and June Nasdaq 100 E-Mini futures (NQM24) are down -0.73% this morning as mixed earnings and the prospect of higher-for-longer U.S. interest rates...

ESM24 : 5,158.25 (+0.07%)
NQM24 : 17,997.75 (-0.02%)
AMD : 150.60 (+3.04%)
SBUX : 73.11 (-2.43%)
AMZN : 186.21 (+0.81%)
GEHC : 79.47 (+2.11%)
FFIV : 165.94 (-0.08%)
WBD : 7.97 (+0.25%)
LLY : 734.97 (-2.77%)
MMM : 97.15 (+0.35%)
MA : 443.58 (+0.56%)
CVS : 55.90 (+1.36%)
Pfizer and Genmab Receive FDA Approval for Cervical Cancer Drug

In late April, Pfizer (NYSE:PFE) and Genmab received approval from the United States Food and Drug Administration ...

PFE : 27.81 (+0.40%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Pfizer Inc. is a research-based, global biopharmaceutical company. The company boasts a sustainable pipeline with multiple late-stage programs that can drive growth. Pfizer markets a wide range of drugs and vaccines. Its business comprises six business units - Oncology, Inflammation & Immunology, Rare...

See More

Key Turning Points

3rd Resistance Point 28.35
2nd Resistance Point 28.13
1st Resistance Point 27.97
Last Price 27.81
1st Support Level 27.58
2nd Support Level 27.36
3rd Support Level 27.20

See More

52-Week High 40.37
Fibonacci 61.8% 34.57
Fibonacci 50% 32.78
Fibonacci 38.2% 30.99
Last Price 27.81
52-Week Low 25.20

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar